Copenhagen, Denmark, April 19, 2025 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of ...

The firings of most of the negotiators and their project managers throw into disarray the complex process of reauthorizing the agreements, overseen by Congress, under which big pharma and generic drug ...

Pharma and medical device companies build their business models on the predictability provided in the user fee agreements, in which the FDA commits to complete new drug reviews within either 10 ...

Nearly three dozen global pharmaceutical companies, in a letter to the head of the European Commission, demanded help to maintain operations in the EU despite threatened US tariffs on imports ...

The heads of 30 pharmaceutical companies have said they are considering diverting as much as €100 billion they had planned to invest in Europe to the United States and other countries instead as ...

In the short term, major pharma companies are expected to absorb the bulk of tariff-related costs on branded medicines. This is according to Reuters, who spoke to Melissa Barber, Postdoctoral ...

Pharmaceutical companies have referred to small molecule drugs’ shorter timeframe for selection as a “pill penalty,” arguing that it could reduce incentives to invest in their development.

It projected India’s pharmaceutical sector to reach $100 billion this year. According to a February report by Bain & Company, the pharmaceutical industry is the fifth-largest contributor to ...

It comes one day after the Trump administration instituted a national security report into the pharmaceutical industry, a precursor to sector-specific tariffs. The ability of Medicare for the first ...

Pharmaceutical companies in recent decades moved production capacity outside of the U.S., including to European Union countries like Ireland in part because of low-income tax rates for ...

Pharma companies are leveraging the United States’ threat of tariffs on drug imports to push for policy changes in the EU. In a letter sent to European Commission President Ursula von der Leyen ...